Stock Events

Stock Events

BioXcel Therapeutics (BX20.F) Q3 2025 Earnings

12AugConfirmed

Q4 2024

Q1 2025

Q2 2025

Q3 2025

-7.68

-5.57

-3.46

-1.35

Details

Expected EPS

-1.59057725

Actual EPS

-2.097935

Surprise EPS

-0.51

Surprise Percent

+31.9%

Description

BioXcel Therapeutics (BX20.F) has reported earnings of -2.097935 per share for Q3 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.